Core Insights - The company reported a continuation of growth dynamics with a 0.5% increase in like-for-like (LFL) net sales in Q3 2025 and a 0.6% increase over the first nine months of the year, confirming the initial results of the "Renouveau" plan [1][8][9] Sales Performance - In Q3 2025, net sales reached €2,002 million, reflecting a 0.5% increase on a like-for-like basis, while convenience brands saw a 1.1% increase [8][12] - For the first nine months of 2025, consolidated net sales totaled €6,080 million, up 0.6% like-for-like, with convenience brands also increasing by 1.1% [9][12] - Monoprix achieved a 0.6% increase in like-for-like net sales in Q3 2025, driven by food sales, particularly fresh products [15][18] - Franprix's net sales decreased by 0.2% on a like-for-like basis in Q3 2025, with a positive impact from the "prix francs" campaign [21][27] EBITDA and Cash Flow - Adjusted EBITDA increased by 13% to €456 million over the first nine months of 2025, raising the margin to 7.5% [3][12] - Free cash flow before financial expenses improved to -€39 million at the end of September 2025, compared to -€48 million at the end of June [5][35] - The company aims to return to break-even free cash flow before financial expenses in 2026 [6] Store Network and Concepts - The company has streamlined its store network, closing 958 outlets and opening 143 stores since the beginning of the year [11] - New store concepts are being rolled out, including the "Oxygène" concept in Franprix and the "La Ferme" concept in Naturalia [11][21][30] - Naturalia reported a strong performance with a 10.4% increase in like-for-like net sales in Q3 2025, supported by a loyal customer base [29][31] Financial Health and Liquidity - The covenant net debt/Covenant adjusted EBITDA ratio was 7.68x at the end of September 2025, below the threshold of 8.34x [6][40] - The Group's liquidity stood at €1.22 billion at the end of September 2025, ensuring financial stability [5][39] Legal Proceedings - The company is involved in legal proceedings related to alleged stock price manipulation and private corruption, with a hearing held in October 2025 [44][45]